California is a big market for this category, and the answer as of September 2026 is workable but needs the full context: 7-OH is not specifically restricted under California’state law, while the federal moves around kratom alkaloids continue to reshape the category. This post covers the state status, the federal overlay, and the practical side for California buyers. Standing caveats: general information, not legal advice; rules change; you own the final call on your own situation. The complete map is in the state-by-state overview.
The state picture in California
- No specific 7-OH ban. As of September 2026, California has not enacted a law specifically targeting 7-hydroxymitragynine products. California is not on the restricted list that carries the 2025–2026 actions: the 7-OH bans in Virginia, Tennessee, Kansas, Florida, and North Dakota, Louisiana’s kratom ban (August 2025), and Massachusetts’s emergency order (August 2026).
- No state kratom ban. California is not among the historical kratom-ban states (Alabama, Arkansas, Iowa, Minnesota, Rhode Island, Vermont, Wisconsin), and no state-level kratom restriction is in effect that we track.
- Regulatory attention is real. California’s general approach to novel consumption products has been active in recent years, and the state s consumer-protection posture means vendors operating here face the same scrutiny everywhere: accurate labeling, verified content, and age gates. That scrutiny is good for the category — it is the environment where the verification-first brands do best.
The federal overlay (what changes under your feet)
Three facts define the 2026 federal picture, and all three matter to a California buyer the same as any other:
- 7-OH itself is not federally scheduled as of September 2026. The pending DEA threshold rule is the one to watch — if it lands, 7-OH products above a potency level become a federal question regardless of state law. The federal status guide is the standing reference.
- Related alkaloids were scheduled August 26, 2026. Mitragynine pseudoindoxyl, MGM-15, and MGM-16 moved to temporary Schedule I. For a 7-OH buyer the practical relevance is the lab panel: a current batch COA should show the related-compound screens. The DEA 2026 update explains the actions and what they do and do not cover.
- State permission does not override federal action. A product that is legal in California can become a federal problem if the pending rule changes the status of the compound class. This is the single most misunderstood point in the category, and the reason the 9-point checklist ranks legal transparency as a vendor criterion.
What it means for a California buyer
- Shipping to California is permitted under our policy: 21+ verification at checkout, adult signature at delivery, discreet packaging, tracking. The shipping guide covers the timeline; the age verification post covers how the 21+ gate works end to end.
- Verify the batch, not just the brand. With the federal threshold rule pending, the batch COA is the document that proves what your pack contains. Match the batch number to the report — how to verify your batch is the step-by-step, and the COA guide is the reading guide.
- Watch the pending rule. If the DEA threshold rule moves, the category picture changes for every state at once. The legal status guide updates when that happens, and the FAQ center carries the standing questions.
Bottom line
As of September 2026: no California’state restriction on 7-OH, a federal picture with related alkaloids scheduled and the 7-OH threshold rule pending, and vendor shipping that serves California addresses with 21+ verification. The responsible pattern is the same in every permitted state: verified units, batch COAs, spacing rules, real breaks, and a current read of the legal map. The shop is open to California addresses, and if your situation has specifics — a workplace policy, a local ordinance you heard about, a medical question — the contact page is for order questions, and your own research or a professional is the right source for the legal ones.